INOreal Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

INOreal General Information

Description

Developer of natural and patented functional ingredients intended for branded nutritional products. The company specializes in offering patented saffron extracts, providing nutrition and health manufacturers with scientifically proven functional ingredients that follow standards of quality and safety.

Contact Information

Website
www.inoreal.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 18C Rue du Sabot
  • 22440 Ploufragan
  • France
+33 04
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Parent Company
Corporate Office
  • 18C Rue du Sabot
  • 22440 Ploufragan
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INOreal Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore INOreal‘s full profile, request access.

Request a free trial

INOreal Patents

INOreal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2007245501-A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity Active 25-Apr-2006
AU-2007245501-B2 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity Active 25-Apr-2006
CA-2648985-A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity Active 25-Apr-2006
CA-2648985-C Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity Active 25-Apr-2006
US-20110236481-A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity Active 25-Apr-2006 A61K36/88
To view INOreal’s complete patent history, request access »

INOreal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

INOreal FAQs

  • When was INOreal founded?

    INOreal was founded in 2008.

  • Where is INOreal headquartered?

    INOreal is headquartered in Ploufragan, France.

  • What is the size of INOreal?

    INOreal has 2 total employees.

  • What industry is INOreal in?

    INOreal’s primary industry is Laboratory Services (Healthcare).

  • Is INOreal a private or public company?

    INOreal is a Private company.

  • What is INOreal’s current revenue?

    The current revenue for INOreal is .

  • When was INOreal acquired?

    INOreal was acquired on 09-Jun-2022.

  • Who acquired INOreal?

    INOreal was acquired by Natac.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process